ARCHIVES

Zofran Label Change Includes Warnings of QT Prolongation

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Tempero, Johnson To Lead ASCO

March 28, 2003

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

CLF Makes Appointments To Board; Stovall Wins Award.

April 20, 2001